PK11195 binding to the peripheral benzodiazepine receptor as a marker of microgila activation in multiple sclerosis and experimental autoimmune encephalomyelitis

Journal of Neuroscience Research

Volumn 50, Issue 2, 1997, Pages 345-353

  Vowinckel, Erika ^a   Reutens, David ^a   Becher, Burkhard ^a   Verge, Gail ^a   Evans, Alan ^a   Owens, Trevor ^a   Antel, Jack P ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

EAE; Microglia; Multiple sclerosis; PK11195

Indexed keywords

BENZODIAZEPINE DERIVATIVE; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL TISSUE; ANTIGEN PRESENTATION; ARTICLE; BINDING SITE; DRUG RECEPTOR BINDING; GLIA CELL; IMMUNOREACTIVITY; LIGAND BINDING; MACROPHAGE ACTIVATION; MICROGLIA; MOUSE; MULTIPLE SCLEROSIS; NERVE INJURY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RECEPTOR AFFINITY;

ANIMALS; BIOLOGICAL MARKERS; BRAIN; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HUMANS; ISOQUINOLINES; MAGNETIC RESONANCE IMAGING; MENINGES; MICE; MICE, INBRED STRAINS; MICROGLIA; MULTIPLE SCLEROSIS; RECEPTORS, GABA-A; REFERENCE VALUES; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0030781925     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19971015)50:2<345::AID-JNR22>3.0.CO;2-5     Document Type: Article

References (37)

1. Anholt RRH, Pedersen PL, De Souza EB, Snyder SH (1986): The peripheral-type benzodiazepine receptor. J Biol Chem 261:576-583.
2. 3 site radioligand. Ann Neurol 24:708-712.
3. Black KL, Idezaki K, Santori E, Becker DP, Vinters HV (1990): Specific high-affinity binding of peripheral benzodiazepine receptor ligands to brain tumors in rat and man. Cancer 65:93-97.
4. 3H]diazepam binding. Proc Natl Acad Sci USA 74(9):3805-3809.
5. Cannella B, Raine CS (1995): The adhesion molecule and cytokine profile of multiple sclerosis lesions. Ann Neurol 37:424-435.
6. 3H]PK11195: Anatomical and subcellular distribution. Brain Res Bull 18:49-61.
7. Drugan RC (1994): Are the nonmitochondrial peripheral benzodiazepine receptors on leucocytes a novel intermediary of brain, behaviour, and immunity? Lab Invest 70:1-3.
8. Francis GS, Evans AC, Arnold DL (1995): Neuroimaging in multiple sclerosis. Neurol Clin 13:147-171.
9. Hardin-Pouzet H, Krakowski M, Boubonnière L, Didier-Bazes M, Tran E, Owens T (1997): Glutamate metabolism is down-regulated in astrocytes during experimental allergic myelitis. Glia 20:79-85.
10. Groom GN, Junck L, Foster NL, Frey KA, Kuhl DE (1995): PET of peripheral benzodiazepine binding sites in the microgliosis of Alzheimer's disease. J Nucl Med 36(12):2207-10.
11. Itzhak YB, Baker L, Norenberg MD (1993): Characterization of the peripheral-type benzodiazepine receptors in cultured astrocytes: evidence for multiplicity. Glia 9:211-218.
12. Klepner CA, Lippa AS, Benson DI, Sano MC, Beer B (1979): Resolution of two biochemically and pharmacologically distinct benzodiazepine receptors. Pharmacol Biochem Behav 11:457-462.
13. Krueger KE (1995): Molecular and functional properties of mitochondrial benzodiazepine receptors. Biochim Biophys Acta 1241: 453-470.
14. 3H]PK11195 in vulnerable regions of the rat brain in thiamine deficiency encephalopathy. J Cereb Blood Flow Metab 14:100-105.
15. 3H]Ro5-4864. Mol Pharmacol 22:26-32.
16. Martin R, McFarland HF, McFarlin D (1992): Immunological aspects of demyelinating disease. Annu Rev Immunol 10:153-87.
17. McCarthy KD, Harden TK (1981): Identification of two benzodiazepine binding sites on cells cultured from rat cerebral cortex. J Pharmacol Exp Ther 216:183-191.
18. Mohler H, Okada T (1977): Benzodiazepine receptors: demonstration in the central nervous system. Science 198:849-851.
19. Olsen JMM, Ciliax BJ, Mancini WR, Young AB (1988): Presence of peripheral-type benzodiazepine binding sites on human erythrocyte membranes. Eur J Pharmacol 152:47-53.
20. 3H-flunitrazepam binding in kianate lesioned rat striatum and in temporal cortex of brains from patients with senile dementia of the Alzheimer type. Brain Res 273:373-375.
21. Owens T, Sriram S (1995): The immunology of MS and of its animal model, EAE. Neural Clin 13:51-73.
22. Park CH, Carboni E, Wood PL, Gee KW (1996): Characterization of peripheral benzodiazepine type sites in a cultured murine BV-2 microglial cell line. Glia 16:65-70.
23. Raine CS (1985): Experimental allergic encephalomyelitis and experimental allergic neuritis. In Koetsier JC (ed): "Handbook of Clinical Neurology." New York: Elsevier Science Publishing Co, Inc., pp 429-466.
24. Ramsay SC, Weiller C, Myers C, Cremer JE, Luthra SK, Lammertsma AA, Frackowiak RSJ (1992): Monitoring by PET of macrophage accumulation in brain after ischemic stroke. Lancet 339:1054-1055.
25. Renno T, Taupin V, Bourbonniere L, Verge G, Krakowski M, De-Simone R, Rodriguez M, Peterson A, Owens T (1997): Transgenic expression of Interferon-gamma in the CNS results in persistent demyelination and neurological deficit following acute EAE. (submitted).
26. Ruff MR, Pert BC, Weber RJ, Wahl LM, Wahl SM, Paul SM (1985): Benzodiazepine receptor-mediated chemotaxis of human monocytes. Science 229:1281-1283.
27. 3H]Ro5-4864 benzodiazepine binding in the kainate lesioned striatum and Huntington's diseased basal ganglia. Brain Res 248:396-401.
28. Sobel RA (1995): The pathology of multiple sclerosis. Neurol Clin 13:1-21.
29. Sriram S, Rodriguez M (1997): Indictment of the microglia as the villain in multiple sclerosis. Neurology 48:464-470.
30. Stephenson DT, Schober DA, Smalstig EB, Mincy RE, Gehlert DR, Clems JA (1995): Peripheral benzodiazepine receptors are colocalized with activated microglia following transient global forebrain ischemia in the rat. J Neurosci 15:5263-5274.
31. Tacite A, Mitsuka S, Diksic M, Yamamoto YL (1992): Autoradiographic study of peripheral benzodiazepine receptors in animal brain tumour models and human gliomas. Eur J Pharmacol 228:131-139.
32. Tallman JF, Pau SM, Skolnick P, Gallager DW (1980): Receptors for the age of anxiety: pharmacology of benzodiazepines. Science 207:274-281.
33. Taupin V, Renno T, Bourbonniere L, Peterson A, Rodriguez M, Owens T (1997): Increased severity of EAE, chronic macrophage/ microglial reactivity and demyelination in transgenic mice producing tumor necrosis factor-alpha in central nervous system. Eur J Immunol 27:905-913.
34. Verma A, Snyder SH (1989): Peripheral type benzodiazepine receptors. Annu Rev Pharmacol Toxicol 29:307-322.
35. Zavala F, Lenfant M (1987): Benzodiazepines and PK11195 exert immunomodulating activities by binding to a specific receptor on macrophages. Ann NY Acad Sci 496:240-249.
36. Zavala F, Haumont J, Lenfant M (1984): Interaction of benzodiazepines with mouse macrophages. Eur J Pharmacol 106:561-566.
37. Zavala F, Taupin V, Descamps-Latscha B (1990): In vivo treatment with benzodiazepines inhibits murine phagocyte oxidative metabolism and production of interleukin 1, tumor necrosis factor and interleukin-6. J Pharmacol Exp Ther 255:442-450.